Shares of Ironwood Pharmaceuticals Inc. (IRWD) have lost a whopping 74% from their 52-week high of $15.70, recorded in February of this year, and trade around $4.The company is anticipating an update on CNP-104 this quarter. This update could potentially influence IRWD's stock performance. CNP-104 is a biodegradable nanoparticle encapsulating PDC-E2 being developed by COUR Pharmaceuticals. The E2 ...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.